Kheiron Medical Technologies (DeepHealth)
London AI company whose Mia breast screening reader was evaluated across NHS sites before its 2024 acquisition by RadNet's DeepHealth.
Overview
Kheiron's Mia received the CE mark in 2019, won an NHS AI Award in 2020 and was deployed as an independent second reader in NHS breast screening evaluations. It became part of DeepHealth (RadNet) in 2024 and its technology now sits inside DeepHealth SmartMammo.
Scorecard
All companies- modalities +2
- regions +1
- registry trials +4
Pages like this
not linked directly; found by shared links- CompanyKheiron Medical Technologies
Shares Mammography & tomosynthesis, AI in radiology, HR-positive / HER2-negative breast cancer.
- CompanyTherapixel
Shares Mammography & tomosynthesis, AI in radiology, HR-positive / HER2-negative breast cancer.
- CompanyVara
Shares Mammography & tomosynthesis, AI in radiology, HR-positive / HER2-negative breast cancer.
- ProductLunit INSIGHT MMG
Shares Mammography & tomosynthesis, AI in radiology, HR-positive / HER2-negative breast cancer.
- CompanyiCAD (RadNet)
Shares Mammography & tomosynthesis, AI in radiology, HR-positive / HER2-negative breast cancer.
- CompanyVolpara Health
Shares Mammography & tomosynthesis, AI in radiology, HR-positive / HER2-negative breast cancer.
- ProductProFound AI (iCAD)
Shares Mammography & tomosynthesis, AI in radiology, HR-positive / HER2-negative breast cancer.
- PersonKristina Lång
Shares Mammography & tomosynthesis, AI in radiology, HR-positive / HER2-negative breast cancer.